Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Saquinavir

Related Products

Hot Products

Name

Saquinavir

EINECS 1806241-263-5
CAS No. 127779-20-8 Density 1.211 g/cm3
PSA 166.75000 LogP 4.90330
Solubility 35.8mg/L(25 oC) Melting Point 91.5oC
Formula C38H50N6O5 Boiling Point 1015 °C at 760 mmHg
Molecular Weight 670.852 Flash Point 567.7 °C
Transport Information N/A Appearance N/A
Safety Risk Codes N/A
Molecular Structure Molecular Structure of 127779-20-8 (Saquinavir) Hazard Symbols N/A
Synonyms

Butanediamide,N1-[3-[3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-,[3S-[2[1R*(R*),2S*],3a,4ab,8ab]]-;(S)-N-[(aS)-a-[(1R)-2-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl]-1-hydroxyethyl]phenethyl]-2-quinaldamidosuccinamide;Fortovase;Ro 31-8959/000;Sch 52852;

Article Data 6

Saquinavir History

  Saquinavir (CAS No.127779-20-8) was the first protease inhibitor (and sixth antiretroviral) ,which was approved on December 6, 1995 by the Food and Drug Administration (FDA) .
  It was approved again on Nov 7, 1997 as Fortovase, a soft gel capsule reformulated for improved bioavailability.
  Roche announced in May 2005 that, owing to reduction in demand, Fortovase would cease being marketed early in 2006 in favour of Invirase boosted with ritonavir.

Saquinavir Specification

The Saquinavir, with the CAS registry number 127779-20-8, is also known as N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-butanediamide. It belongs to the product categories of Active Pharmaceutical Ingredients; Saquinavir. This chemical's molecular formula is C38H50N6O5 and molecular weight is 670.84. What's more, its IUPAC name is called (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide. The production is an antiretroviral drug used in HIV therapy. In addition, it falls in the protease inhibitor class. The most frequent adverse events with saquinavir in either formulation are mild gastrointestinal symptoms, including diarrhea, nausea, loose stools & abdominal discomfort. This chemical can be prepared by N-Phthalic acyl-(S)-styrene-acrylic ammonia carbonyl chlorides with 1,1,2-Tris(trimethylsilyloxy)ethene. This reaction needs reagent HCl and solvents ethyl acetate, hexane.

Physical properties about Saquinavir are: (1)ACD/LogP: 4.03; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): 1.96; (4)ACD/LogD (pH 7.4): 3.61; (5)ACD/BCF (pH 5.5): 5.79; (6)ACD/BCF (pH 7.4): 260.25; (7)ACD/KOC (pH 5.5): 31.52; (8)ACD/KOC (pH 7.4): 1417.08; (9)#H bond acceptors: 11; (10)#H bond donors: 6; (11)#Freely Rotating Bonds: 14; (12)Polar Surface Area: 106.6 Å2; (13)Index of Refraction: 1.598; (14)Molar Refractivity: 189.12 cm3; (15)Molar Volume: 553.8 cm3; (16)Surface Tension: 54.2 dyne/cm; (17)Density: 1.211 g/cm3; (18)Flash Point: 567.7 °C; (19)Enthalpy of Vaporization: 155.26 kJ/mol; (20)Boiling Point: 1015 °C at 760 mmHg; (21)Vapour Pressure: 0 mmHg at 25 °C.

You can still convert the following datas into molecular structure:
(1) SMILES: O=C(N)C[C@H](NC(=O)c1nc2c(cc1)cccc2)C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN5[C@H](C(=O)NC(C)(C)C)C[C@@H]4CCCC[C@@H]4C5
(2) InChI: InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1
(3) InChIKey: QWAXKHKRTORLEM-UGJKXSETSA-N

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 127779-20-8